![ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke](https://www.ahajournals.org/cms/asset/b1643d7c-9361-473e-aef5-b00ccaaa6898/1262fig01.jpg)
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke
![Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy - ScienceDirect Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1056872716305086-gr1.jpg)
Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy - ScienceDirect
![ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke](https://www.ahajournals.org/cms/asset/86bddd70-d9a1-4f61-9300-cefd607e0bbb/1262fig01.jpeg)
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke
![ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke](https://www.ahajournals.org/cms/asset/04aff948-fb95-49a2-8a2a-c9f8d3eacfbb/1262fig03.jpeg)
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke
![ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) | Stroke](https://www.ahajournals.org/cms/asset/680bc90e-cc04-41f5-86e6-f4164a4f1306/1262fig02.jpeg)